Panagora Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,807
Closed -$210K 2584
2018
Q3
$210K Sell
10,807
-28,283
-72% -$602K ﹤0.01% 1661
2018
Q2
$999K Sell
39,090
-122,905
-76% -$2.87M ﹤0.01% 1146
2018
Q1
$3.26M Buy
161,995
+36,791
+29% +$858K 0.01% 691
2017
Q4
$2.51M Buy
125,204
+124,780
+29,429% +$2.45M 0.01% 784
2017
Q3
$9K Sell
424
-1,202
-74% -$20.3K ﹤0.01% 2246
2017
Q2
$24K Sell
1,626
-6,958
-81% -$116K ﹤0.01% 2228
2017
Q1
$137K Buy
+8,584
New +$124K ﹤0.01% 1772

Other funds holding DPLO

Panagora Asset Management's DPLO Position: Q4 2018 in Review

Panagora Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 10,807 shares — an estimated $210K sold.

Panagora Asset Management first reported a position in DPLO in Q1 2017 and held it in 7 quarters. The position peaked at $3.26M in Q1 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Panagora Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Panagora Asset Management sold 10,807 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $210K.
  • Panagora Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 7 quarters.
  • Panagora Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $3.26M in Q1 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Panagora Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.